Harvard researchers look toward nature to beat cancer
Dramatic responses in cancerous mice that received the vaccine spurred Mooney and his collaborators at the Dana-Farber Cancer Institute (DFCI) to start a phase 1 clinical trial with support from both institutes, to see if it had the same effect in human patients. This kind of study is usually undertaken by hospitals and pharmaceutical companies,… Read More »